At a glance
What is it—and why does it matter?
SS-31 and elamipretide refer to the same peptide (a synonym/name pairing).
Sources for this introduction: [1]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
SS-31 and elamipretide refer to the same peptide (a synonym/name pairing).
- Source records
- 1
- Independent studies
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“SS-31 (elamipretide)”
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. · Abstract
pubmed:41966639:9547b381c1d2:9547b381c1d2
How does it work?
Target, response, and disposition.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
- 1 compiled claim(s) withheld by automated assurance: assurance_score_below_0.72 (1), current_regulatory_source_required (1), extraction_ambiguity (1), high_risk_requires_regulatory_or_two_independent_sources (1), no_direct_support (1)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. ↗
pubmed · published 2026-08-01 · retrieved 2026-08-17T23:10:15Z
Publication history and provenance
Version 2 · Automated assessment · 2026-08-17T23:10:15Z
83db58b2a806bf8f4c9bef31f8e0b7eb46fca79f49d13859538617e89cbf0174